Kraig Biocraft Laboratories Inc (KBLB)

[Chompiee]

News




Kraig Biocraft Laboratories’ Succeeds in Doubling Its Production of Monster Silk™


Kraig Achieves another Milestone in Spider Silk Commercialization



LANSING, Mich., July 9, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced that its Monster Silk™ production program has successfully doubled in size, achieving another major milestone in the Company’s spider silk commercialization process.


“Earlier this year, we set ambitious goals for the growth of our Company and for the production of genetically engineered spider silk,” said Company Founder and CEO, Kim K Thompson “Since then, we have expanded our productive capacity in order to make that growth a reality. The current production run is by far the largest in the Company’s history. The doubling of production is an important milestone in the commercialization of spider silk and is affirmation of the success of our production plan and commercialization strategy,” stated Thompson.